Annual Report

Overview

The report presents Sandu Pharmaceuticals' FY2019-20 performance, including Revenue From Operations of INR 483,674,955 and Total Income of INR 488,202,436. It describes COVID-19 disruption, temporary production curtailment, and development and promotion of a preventive kit. The report also discloses energy-use inputs, identifies one woman director on the eight-member board, and states that CSR requirements were not applicable.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2019-2020
Period: 1 April 2019 – 31 March 2020
Publication date: 7 September 2020
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services